Sun Pharma introduces a novel class of drug, Fexuclue (Fexuprazan) in India
Sun Pharmaceutical Industries Limited announced that it has launched Fexuprazan tablets 40 mg in India under the brand name “FEXUCLUE® ”. FEXUCLUE® , a novel potassium- competitive acid blocker (PCAB), is approved as a new treatment for adults with Erosive Esophagitis of all grades.










